首页> Pharmacogenetics and genomics> Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer

Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer

导出原文传递

翻译打印收藏纠错

第一作者： Vincent Menard

作者： Vincent Menard ^[1] ; Eric Levesque ; Sylvia Chen ; Olivier Eap ; Melanie S. Joy ; Lena Ekstrom ; Anders Rane ; Chantal Guillemette

作者单位： Pharmacogenomics Laboratory,Centre Hospitalier de I'Universite Laval de Quebec (CHU de Quebec ^[1]

关键词 alternative promoters alternative splicing glucuronosyltransferase UGT2B7

发布时间 2014-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmacogenetics and genomics

2013年23卷12期

684-696页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Pharmacogenetics and genomics

2013年23卷12期

684-696页

检索历史清除

Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer

Pharmacogenetics and genomics

相似文献

同项目论文

Pharmacogenetics and genomics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer

Pharmacogenetics and genomics

相似文献

同项目论文

Pharmacogenetics and genomics

相关期刊

检索历史清除